AU2014250643B2 - Treatment of portal hypertension and restoration of liver function using L-ornithine phenylacetate - Google Patents
Treatment of portal hypertension and restoration of liver function using L-ornithine phenylacetateInfo
- Publication number
- AU2014250643B2 AU2014250643B2 AU2014250643A AU2014250643A AU2014250643B2 AU 2014250643 B2 AU2014250643 B2 AU 2014250643B2 AU 2014250643 A AU2014250643 A AU 2014250643A AU 2014250643 A AU2014250643 A AU 2014250643A AU 2014250643 B2 AU2014250643 B2 AU 2014250643B2
- Authority
- AU
- Australia
- Prior art keywords
- liver function
- restoration
- treatment
- portal hypertension
- ornithine phenylacetate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
TREATMENT OF PORTAL HYPERTENSION AND RESTORATION OF LIVER FUNCTION USING L-ORNITHINE PHENYLACETATE Disclosed herein are methods of treating and/or preventing portal hypertension and/or restoring liver function using L-ornithine phenylacetate.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2014250643A AU2014250643B2 (en) | 2009-06-08 | 2014-10-15 | Treatment of portal hypertension and restoration of liver function using L-ornithine phenylacetate |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61/185,158 | 2009-06-08 | ||
| US61/240,748 | 2009-09-09 | ||
| US61/296,377 | 2010-01-19 | ||
| AU2010258888A AU2010258888B2 (en) | 2009-06-08 | 2010-06-08 | Treatment of portal hypertension and restoration of liver function using L-ornithine phenylacetate |
| AU2014250643A AU2014250643B2 (en) | 2009-06-08 | 2014-10-15 | Treatment of portal hypertension and restoration of liver function using L-ornithine phenylacetate |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2010258888A Division AU2010258888B2 (en) | 2009-06-08 | 2010-06-08 | Treatment of portal hypertension and restoration of liver function using L-ornithine phenylacetate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2014250643A1 AU2014250643A1 (en) | 2014-11-06 |
| AU2014250643B2 true AU2014250643B2 (en) | 2016-07-14 |
Family
ID=51845146
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2014250643A Active AU2014250643B2 (en) | 2009-06-08 | 2014-10-15 | Treatment of portal hypertension and restoration of liver function using L-ornithine phenylacetate |
Country Status (1)
| Country | Link |
|---|---|
| AU (1) | AU2014250643B2 (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI2153870T1 (en) | 2004-11-26 | 2014-05-30 | Ucl Business Plc | Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy |
| HUE035921T2 (en) | 2009-04-03 | 2018-05-28 | Ocera Therapeutics Inc | L-Ornithine Phenylacetate and Methods of Preparation |
| CN104434894A (en) | 2009-06-08 | 2015-03-25 | Ucl商业有限公司 | Reatment of portal hypertension using l-ornithine phenylacetate |
| ES2769000T3 (en) | 2014-11-24 | 2020-06-24 | Ucl Business Ltd | Treatment of diseases associated with the activation of liver stellate cells using ammonia-reducing therapies |
| CN107708684A (en) * | 2015-04-20 | 2018-02-16 | 欧塞拉治疗有限公司 | L-ornithine phenylacetate preparation |
| WO2017031131A1 (en) | 2015-08-18 | 2017-02-23 | Ocera Therapeutics, Inc. | Treatment and prevention of muscle loss using l-ornithine in combination with at least one of phenylacetate and phenylbutyrate |
| CN108366983A (en) | 2015-11-13 | 2018-08-03 | 欧塞拉治疗有限公司 | L-ornithine phenylacetate preparation |
| US11219611B2 (en) | 2015-11-13 | 2022-01-11 | Ocera Therapeutics, Inc. | Formulations of L-ornithine phenylacetate |
| MX389665B (en) | 2017-05-11 | 2025-03-20 | Ocera Therapeutics Inc | PROCESSES FOR PRODUCING L-ORNITHINE PHENYLACETATE |
-
2014
- 2014-10-15 AU AU2014250643A patent/AU2014250643B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| AU2014250643A1 (en) | 2014-11-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2020009703A (en) | Treatment of portal hypertension and restoration of liver function using l-ornithine phenylacetate. | |
| AU2014250643B2 (en) | Treatment of portal hypertension and restoration of liver function using L-ornithine phenylacetate | |
| PH12017500930A1 (en) | Hsp90 inhibitor combinations | |
| WO2012037155A3 (en) | Tyrosine kinase inhibitors | |
| MX2009009292A (en) | Ppar active compounds. | |
| WO2009111676A8 (en) | Boron-containing small molecules as anti-inflammatory agents | |
| MX2009009761A (en) | Compositions and kits for treating influenza. | |
| AU2016204376A1 (en) | MicroRNA-based methods and compositions for the diagnosis and treatment of ovarian cancer | |
| MX2010009765A (en) | Boron-containing small molecules as anti-inflammatory agents. | |
| EA201291031A1 (en) | METHOD OF TREATING OBESITY WITH THE USE OF ANTIOXIDANT INFLAMMATION MODULATORS | |
| BR112012018761A2 (en) | structures to prevent microorganism fixation | |
| MX2010005395A (en) | Method of treating arthritis. | |
| MX2009005725A (en) | Methods and compositions for treating and monitoring treatment of il-13-associated disorders. | |
| WO2011100295A3 (en) | Alpha-methyl-tryptophan as an inhibitor of indoleamine dioxygenase | |
| WO2012073047A3 (en) | Compositions and methods | |
| WO2010132622A3 (en) | Anticd20-cpg conjugates and methods of treating b cell malignancies | |
| MX341340B (en) | Flame treatment of a substrate. | |
| WO2012074725A3 (en) | Immunomodulatory methods and systems for treatment and/or prevention of hypertension | |
| WO2012061086A3 (en) | Method of treating neuroendocrine tumors | |
| EP2597949A4 (en) | Sub-micron compositions | |
| WO2011110367A3 (en) | Method of screening for htra protease inhibitors useful for prophylaxis and therapy of a bacterial infection | |
| TN2011000214A1 (en) | Combination of hsp90 and herceptin inhibitors | |
| WO2011006097A3 (en) | Methods For Treating Toxicity | |
| WO2009100445A3 (en) | Compositions and methods which modulate g-protein signaling for the treatment of asthma | |
| AU2015201137B2 (en) | Compositions and method for tissue preservation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) |